Here is the link to the publication (Current Bladder Dysfunction
Reports,December 2012, Volume 7, Issue 4, pp 286-293,Management of Male Voiding Dysfunction after Radical Cystectomy
and Neobladder Reconstruction, by Richard E. Hautmann). Here is the Abstract:
"At centers orthotopic bladder substitution (OBS) is the
preferred method of urinary diversion following radical cystectomy (RC). Daytime
and nighttime incontinence (UI) are reported in up to 13% and 28% of cases,
respectively. SUI is the most common reason for daytime leakage, while an absent
vesicourethral reflex with reduced external sphincter tone is associated with
nighttime UI. A PubMed search disclosed a paucity of data for any treatment
modality, the absence of prospective randomized trials and the existence of few
retrospective case reports or small case series with limited follow up.
Conservative management has limited value. Pharmacologic treatment for enuresis
is effective in select OBS patients, while the off label use of Duloxetine for
SUI seems promising. Surgical approaches include adjustable and nonadjustable
slings as well as the ProACT system in mild stress UI. The need of intermittent
self catheterisation (ISC) after slings seems to be very high. Implantation of
the artificial urinary sphincter AMS 800 (AUS) is the standard treatment for
severe stress (UI). AUS is a relatively safe, effective continence procedure for
patients with OBS and severe SUI. Complication rate, urinary symptoms, and
quality of life of these patients as determined by validated questionnaires are
acceptable."
That's the good news. The bad news is that Duloxetine failed the US approval for stress urinary incontinence amidst concerns over liver toxicity and suicidal events. Duloxetine was approved in Europe for SUI, where it is recommended as
an add-on medication instead of surgery.
In the US, Duloxetine is approved in the US for major depressive disorder and generalized depressive disorder. It can also relieve the symptoms of painful periphia neuropathy, particularly diabetic neuropathy, and it is used to control the symptoms of fibromyalgia.
So the question is whether I should try Duloxetine for my incontinence. I've already emailed Dr. Schoenberg at Hopkins and asked for his opinion. I'll also ask Dr. Plimack at Fox Chase when I see her next month, and my local urologist when I see him in early April. The question is, what's worse: incontinence and not sleeping, or the risk of liver toxicity and suicidal events?